Management of chronic obstructive pulmonary disease in Australia after the publication of national guidelines

Internal Medicine Journal

Volumn 41, Issue 3, 2011, Pages 263-270

  Ta, M ^a   George, J ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Adherence; Chronic obstructive pulmonary disease; Exacerbation; Hospitalization

Indexed keywords

ANTIBIOTIC AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; IPRATROPIUM BROMIDE; PREDNISOLONE; THEOPHYLLINE; TIOTROPIUM BROMIDE;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLINICAL ARTICLE; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HUMAN; INHALER; INTERVIEW; LONG TERM CARE; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PULMONARY REHABILITATION;

ADULT; AGED; AGED, 80 AND OVER; AUSTRALIA; CROSS-SECTIONAL STUDIES; DISEASE MANAGEMENT; FEMALE; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 79952997898     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2009.02133.x     Document Type: Article

References (26)

1. Australian Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Case Statement 2001 [cited 2007 Sep 8]. Available from: URL:
2. McKenzie DK, Abramson M, Crockett AJ, Glasgow N, Jenkins S, McDonald C etal. The COPD-X Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2007 [cited 2007 Sep 8]. Available from: URL:
3. Chapman KR, Mannino DM, Soriano JB, Vermeire PA, Buist AS, Thun MJ etal. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J 2006; 27: 188-207.
4. Pauwels RA, Buist AS, Calverley PMA, Jenkins CR, Hurd SS, GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop Summary. Am J Respir Care Med 2001; 163: 1256-76.
5. Frith P. Pulmonary Rehabilitation in Australia: Evidence Base and Standards 2008 [cited 2008 Oct 22]. Available from: URL:
6. Jadwiga AW, Donaldson GC. Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48: 1204-15.
7. Rodri{dotless}guez-Roisin R. COPD exacerbations-5 management. Thorax 2006; 61: 535-44.
8. Garcia-Aymerich J, Monso E, Marrades RM, Escarrabill J, Felez MA, Sunyer J etal. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation (EFRAM study). Am J Respir Crit Care Med 2001; 164: 1002-7.
9. Garcia-Aymerich J, Barreiro E, Farrero E, Marrades RM, Morera J, Anto JM. Patients hospitalized for COPD have a high prevalence of modifiable risk factors for exacerbation (EFRAM study). Eur Respir J 2000; 16: 1037-42.
10. Australian Lung Foundation. Chronic Obstructive Pulmonary Disease (COPD) Prevalence and Treatment 2004 Nov 17 [cited 2007 Sep 8]. Available from: URL:
11. Matheson MS, Abeysena C, Raven JM, Skoric B, Johns DP, Abramson MJ etal. How have we been managing chronic obstructive pulmonary disease in Australia? Intern Med J 2006; 36: 92-9.
12. Asthma Foundation of Australia. Asthma medications and delivery devices 2005 [cited 2007 Nov 4]. Available from:
13. Bourbeau J, Bartlett SJ. Patient adherence in COPD. Thorax 2008; 63: 831-8.
14. George J, Kong DCM, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest 2005; 128: 3198-204.
15. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50years of research. Med Care 2004; 42: 200-9.
16. Rapoff MA, Bartlett SJ. Adherence in children and adults. In: Bartlett SJ, ed. Clinical Care in the Rheumatic Diseases. Atlanta, GA: American College of Rheumatology; 2006; 279-84.
17. Van der Palen J, Klein JJ, Kerkhoff AHM, Van Herwaarden CLA. Evaluation of the effectiveness of four different inhalers in patients with chronic obstructive pulmonary disease. Thorax 1995; 50: 1183-7.
18. Lavorinia F, Magnan A, Dubus JC, Voshaar T, Corbetta L, Broeders M etal. Effect of incorrect use of dry powder inhalers on management of patients with asthma and COPD. Respir Med 2008; 102: 593-604.
19. Virchow JC, Crompton GK, Dal Negro R, Pedersen S, Magnan A, Seidenberg J etal. Importance of inhaler devices in the management of airway disease. Respir Med 2008; 102: 10-19.
20. Arnold E, Bruton A, Ellis-Hill C. Adherence to pulmonary rehabilitation: a qualitative study. Respir Med 2006; 100: 1716-23.
21. Lucasa AEM, Smeenkb FWJM, Smeelec IJ, van Schayck CP. Overtreatment with inhaled corticosteroids and diagnostic problems in primary care patients, an exploratory study. Fam Pract 2008; 25: 86-91.
22. Devereux G. ABC of chronic obstructive pulmonary disease: definition, epidemiology, and risk factors. BMJ 2006; 332: 1142-4.
23. Bakke PS, Baste V, Hanoa R, Gulsvik A. Prevalence of obstructive lung disease in a general population: relation to title and exposure to some airborne agents. Thorax 1991; 46: 863-70.
24. Rand CS. I took the medicine like you told me, doctor: self-report of adherence with medical regimens. In: Stone A, ed. The Science of Self-Report: Implications for Research and Practice. Mahwah, NJ: Lawrence Erlbaum Associates; 2000; 257-76.
25. Haynes RB, Sackett DL, Taylor DW. How to detect and manage low patient compliance in chronic illness. Geriatrics 1980; 35: 91-7.
26. Anthonisen NR, Connett JE, Kiley JP, Altose MD, Bailey WC, Buist AS etal. Effects of smoking interventions and the use of inhaled anticholinergic bronchodilator on the rate of decline on FEV1: the Lung Health Study. JAMA 1994; 272: 1497-505.